Granted Patent
B2
US 8,198,483 · App. 13/165,037 · Granted Jun 12, 2012
Phenethanolamine derivatives for treatment of respiratory diseases
Assignee:
Glaxo Group Limited
View Patent ↗
Loading inventors, assignments & file history…
Abstract
(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)ethanol and (5R)-3-(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)-5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one are claimed.
Claims (2)
1. A compound which is (1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)ethanol.
2. (5R)-3-(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)-5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one.
Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Mar 1, 2013
From: BOX, PHILIP CHARLES; COE, DIANE MARY; LOOKER, BRIAN EDGAR; MANN, INDERJIT SINGH; PROCOPIOU, PANAYIOTIS ALEXANDROU
To: GLAXO GROUP LIMITED
Reel/Frame 029903/0936 →
Priority Claims (2)
GB 0122201.7
· Sep 14, 2001
· national
GB 0126997.6
· Nov 9, 2001
· national
Continuity (5)
Continuation
10489569